PetMed Express Inc (PETS)

PetMed Express Inc is a common stock listing on NASDAQ for a U.S.-based pet pharmacy business. Through its subsidiaries, the company sells prescription and non-prescription medications, health products, and related supplies for dogs, cats, and horses. Its assortment includes items for flea and tick control, joint care, vitamins, treats, nutritional supplements, hygiene products, household pet supplies, and a range of prescription treatments such as heartworm preventatives, arthritis, dermatitis, thyroid, diabetes, pain, and cardiovascular medications, along with generic substitutes. The company also distributes pet food, beds, crates, stairs, and other pet products. PetMed Express reaches customers through its website, mobile app, customer support center, and direct-mail and print channels. Incorporated in 1996, the company is headquartered in Delray Beach, Florida.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-PETS
$1.65
33.3% Upside
Undervalued
$1.40
12.9% Upside
Fair
Weak
0.0%
November 10, 2026
1.1x
0.2x
26.105 M
13.449 M
1.6%
63.0%
1.5
-0.1%
94.9%
Valuation • Fair Value

PetMed Express Inc (NASDAQ-PETS) Fair Value by Valuation Model

Review the available estimates for PetMed Express Inc (NASDAQ-PETS), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.65

Estimated upside of 33.3% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.71

Discounted cash flow valuation reference.

Comps Fair Value

$1.60

Comparable-company valuation reference.

Analyst Price Target

$1.40

Analysts imply upside of 12.9%.

How to read these valuation models

Use the 5 available valuation references for PetMed Express Inc (NASDAQ-PETS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for PetMed Express Inc (NASDAQ-PETS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

168.9 M

Current operating scale indicator.

Revenue Forecast

149.2 M

Forward revenue estimate.

EBITDA

-18.588 M

Current operating profitability reference.

EBITDA Forecast

5.108 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review PetMed Express Inc (NASDAQ-PETS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for PetMed Express Inc (NASDAQ-PETS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-2.62

No elevated caution signal from this screen.

Altman Z-Score

1.5

Lower score that deserves closer risk review.

FCF / Net Income

94.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for PetMed Express Inc (NASDAQ-PETS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for PetMed Express Inc (NASDAQ-PETS)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 10, 2026

Days to Earnings

4

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

-0.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for PetMed Express Inc (NASDAQ-PETS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

PetMed Express Inc (NASDAQ-PETS) Stock Forecast & Technical Outlook

Review PetMed Express Inc (NASDAQ-PETS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for PetMed Express Inc (NASDAQ-PETS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for PetMed Express Inc (NASDAQ-PETS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for PetMed Express Inc (NASDAQ-PETS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for PetMed Express Inc (NASDAQ-PETS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for PetMed Express Inc (NASDAQ-PETS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for PetMed Express Inc (NASDAQ-PETS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Sell

Based on the available recommendation mix, PetMed Express Inc (NASDAQ-PETS) has a Strong Sell consensus, with 0 buy, 0 hold and 1 sell recommendations in the current data set.

Buy 0
Hold 0
Sell 1
FAQ • Fast Investor Answers

PetMed Express Inc (NASDAQ-PETS) Stock FAQ

Data-supported answers about PetMed Express Inc (NASDAQ-PETS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.65
Estimated upside 33.3%
Valuation Rating
Undervalued
Estimated upside of 33.3%
Analyst Target
$1.40
Implied upside 12.9%
Financial Health
Weak
Current financial-health read

The current fair value estimate for PetMed Express Inc (NASDAQ-PETS) is $1.65. This implies an estimated upside of 33.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 33.3% versus the current market price.

The available analyst price target for PetMed Express Inc (NASDAQ-PETS) is $1.40. The analyst target implies estimated upside of 12.9%.

The current financial health read for PetMed Express Inc (NASDAQ-PETS) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for PetMed Express Inc (NASDAQ-PETS) is November 10, 2026.

The latest available data indicates no current dividend yield for PetMed Express Inc (NASDAQ-PETS).

The current market capitalization listed for PetMed Express Inc is 26.105 M.

The current enterprise value listed for PetMed Express Inc is 13.449 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for PetMed Express Inc is NASDAQ-PETS, and the stock is listed on NASDAQ.

PetMed Express Inc (NASDAQ-PETS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for PetMed Express Inc is 1.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for PetMed Express Inc is 63.0%. Free float helps investors understand how much of the share base is available for public trading.